Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.41   +0.007 (1.74%)  0.40 - 0.415  83,400

Overview

 
Avg Volume (4 weeks):88,650
4 Weeks Range:0.388 - 0.449
4 Weeks Price Volatility (%):
36.07%
52 Weeks Range:0.365 - 0.85
52 Weeks Price Volatility (%):
9.28%
Average Price Target: 3.00
Price Target Upside/Downside: +2.59

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers